GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; Trelegy Ellipta for the treatment of chronic obstructive pulmonary disease; and Seretide. In addition, the company offers general medicines, including Augmentin, an oral antibiotic for respiratory tract infections, surgical prophylaxis, dental infections, and skin infections; Ceftum, an anti-infective medicine; Calpol and Calpol T for pain management; Eltroxin for the treatment of hypothyroidism; Neosporin, Betnovate, T-bact, Physiogel, Tenovate, and Flutivate for dermatology indications; and CobadexCZS and CCM, which are mineral, vitamins, and nutrition products. Further, it provides oncology medicines, including Jemperli and Zejula. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. The company was incorporated in 1924 and is headquartered in Mumbai, India. GlaxoSmithKline Pharmaceuticals Limited operates as a subsidiary of GSK plc.
Low
2,088.10
High
3,054.90
Low
2,880.00
High
2,989.40
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How GlaxoSmithKline Pharmaceuticals Limited stacks up against its Drug Manufacturers - General peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GLAXO GlaxoSmithKline Pharmaceuticals Limited | 2,883.60 | 3.87% | 45.73 | 63.05 | 49,083 | 19.13% | 8.12% | 3,054.90 / 2,088.10 |
| 2 | CORONA CORONA REMEDIES LIMITED | 2,147.20 | 0.86% | 65.99 | 32.54 | 13,084 | 3.48% | 51.85% | 2,270.10 / 1,336.60 |
| 3 | MARKSANS Marksans Pharma Limited | 321.50 | 0.20% | 28.18 | 11.41 | 14,569 | 19.54% | 26.08% | 345.50 / 155.00 |
| 4 | NGLFINE NGL Fine-Chem Limited | 2,949.00 | 2.78% | 31.80 | 92.73 | 1,822 | 7.79% | 119.75% | 3,602.00 / 1,271.00 |
| 5 | PFIZER Pfizer Limited | 4,975.00 | 1.12% | 30.96 | 160.70 | 22,759 | 5.04% | 7.00% | 5,765.00 / 4,360.10 |
| 6 | RUBICON RUBICON RESEARCH LIMITED | 1,727.00 | 1.91% | 98.95 | 17.45 | 28,587 | 19.68% | 174.78% | 1,820.10 / 570.75 |
| 7 | SAIPARENT SAI PARENTERALS LIMITED | 540.10 | 0.61% | 103.12 | 5.24 | 2,386 | 7.20% | 32.65% | 706.00 / 400.00 |
| 8 | SANOFI Sanofi India Limited | 3,357.00 | 1.08% | 23.88 | 140.59 | 7,731 | 0.42% | 43.31% | 5,291.00 / 3,054.00 |
| 9 | SANOFICONR SANOFI CONS HEALTHC IND L | 4,211.00 | 0.05% | 36.46 | 115.51 | 9,903 | 8.00% | 16.97% | 5,357.00 / 3,975.00 |
| 10 | SENORES SENORES PHARMACEUTICALS L | 1,518.00 | 0.31% | 53.47 | 28.39 | 6,991 | 6.90% | 144.05% | 1,577.50 / 662.45 |
| 11 | SMSPHARMA SMS Pharmaceuticals Limited | 357.00 | 0.14% | 31.76 | 11.24 | 3,330 | 9.86% | 40.88% | 447.80 / 221.02 |
| 12 | TTKHLTCARE TTK Healthcare Limited | 1,105.00 | 2.12% | 21.11 | 52.34 | 1,561 | 9.19% | 17.84% | 1,216.80 / 735.00 |